ASH
Ashland Inc. NYSE$52.26
Mkt Cap $2.4B
52w Low $46.30
30.8% of range
52w High $65.65
50d MA $55.39
200d MA $55.00
P/E (TTM)
-2.8x
EV/EBITDA
-7.0x
P/B
1.2x
Debt/Equity
0.8x
ROE
27.1%
P/FCF
-551.0x
RSI (14)
—
ATR (14)
—
Beta
0.44
50d MA
$55.39
200d MA
$55.00
Avg Volume
721.9K
About
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as th…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | AMC | 0.97 | 0.91 | -6.2% | 57.00 | -3.9% | -13.8% | -6.6% | -9.1% | -7.8% | — | — |
| Feb 2, 2026 | AMC | 0.23 | 0.26 | +13.0% | 61.56 | -3.2% | -0.8% | +4.9% | +2.6% | +4.2% | +1.1% | — |
| Nov 4, 2025 | AMC | 1.17 | 1.08 | -7.7% | 47.84 | +0.4% | +6.1% | +5.1% | +4.6% | +4.3% | +4.6% | — |
| Jul 29, 2025 | AMC | 1.15 | 1.04 | -9.6% | 50.18 | +0.6% | +5.6% | +2.8% | +0.6% | +1.2% | +3.8% | — |
| Apr 30, 2025 | AMC | 1.10 | 0.99 | -10.0% | 54.39 | -9.5% | -9.9% | -9.1% | -8.6% | -11.5% | -11.1% | — |
| Jan 28, 2025 | AMC | 0.79 | 0.28 | -64.6% | 71.16 | -1.8% | -9.8% | -10.4% | -10.8% | -14.4% | -9.4% | — |
| Nov 7, 2024 | AMC | 1.28 | 1.26 | -1.6% | 80.70 | +0.2% | +0.3% | -2.4% | -4.3% | -4.0% | -3.3% | — |
| Aug 6, 2024 | AMC | 1.47 | 1.49 | +1.4% | 90.39 | -8.4% | -9.6% | -8.1% | -9.2% | -7.9% | -7.8% | — |
| Apr 30, 2024 | AMC | 1.14 | 1.27 | +11.4% | 95.33 | +2.0% | -0.9% | +0.5% | +0.5% | +2.1% | +2.8% | — |
| Jan 30, 2024 | AMC | 0.19 | 0.45 | +136.8% | 80.77 | +11.1% | +15.9% | +16.9% | +13.4% | +12.5% | +11.9% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $49.15 | $49.07 | -0.2% | +8.4% | +5.4% | — | — | — |
| Apr 30 | JP Morgan | Maintains | Overweight → Overweight | — | $49.15 | $49.07 | -0.2% | +8.4% | +5.4% | — | — | — |
| Mar 23 | Argus | Maintains | Buy → Buy | — | $48.81 | $50.17 | +2.8% | +2.3% | +4.1% | +9.8% | +11.0% | +9.0% |
| Feb 18 | Evercore ISI | Maintains | In Line → In Line | — | $60.23 | $60.37 | +0.2% | +5.2% | +5.0% | +7.6% | +4.7% | +6.4% |
| Feb 4 | JP Morgan | Maintains | Overweight → Overweight | — | $61.08 | $61.95 | +1.4% | +5.7% | +3.4% | +5.0% | +1.9% | +2.3% |
| Jan 12 | Argus | Maintains | Buy → Buy | — | $62.34 | $62.31 | -0.0% | +3.2% | +2.8% | +3.6% | +2.9% | +0.9% |
| Jan 12 | UBS | Maintains | Buy → Buy | — | $62.34 | $62.31 | -0.0% | +3.2% | +2.8% | +3.6% | +2.9% | +0.9% |
| Dec 19 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $59.27 | $59.10 | -0.3% | +0.3% | +0.4% | -0.3% | +0.2% | +0.7% |
| Dec 18 | Mizuho | Maintains | Outperform → Outperform | — | $59.77 | $59.77 | +0.0% | -0.8% | -0.5% | -0.5% | -1.2% | -0.6% |
| Dec 15 | BMO Capital | Upgrade | Market Perform → Outperform | — | $59.15 | $61.06 | +3.2% | +1.1% | -0.8% | +1.0% | +0.2% | +0.5% |
Recent Filings
Data updated apr 24, 2026 7:12pm
· Source: massive.com